title: In vitro expansion of CD34+ cells mobilized with chemotherapy and G-CSF.
abstract: Hemopoietic CD34+ progenitors were isolated by immunomagnetic method from normal bone marrow (BM) or from peripheral blood (PB) of patients with non-Hodgkin's lymphoma treated with chemotherapy and granulocyte colony-stimulating factor (GCSF). Aliquots were seeded in long-term cultures (LTC) on bone marrow-derived stromal layers; non-adherent and adherent clonogenic content of the cultures was assayed weekly. The final recovery and the clonogenic efficiency of the CD34+ cells were slightly higher in PB samples than in BM controls. In long term cultures PB cells sustained hemopoiesis as much as BM cells; at week 3 and 4 PB total mononuclear cells and CD34+ cells showed a non-adherent cell recovery higher than the respective BM controls. Furthermore, PB CD34+ cells were expanded in liquid culture in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF alone or combined with interleukin 3 (IL3), stem cell factor (SCF), interleukin 1 (IL1), interleukin 6 (IL6). The combination of GM-CSF, IL3, SCF, IL1 and IL6 produced the maximum increase of both mononuclear cells (30-fold) and granulocyte-macrophage colony forming units (CFU-GM) (4.6-fold) after 7 days of cultures; yet after 14 days a strong decrease of the CFU-GM occurred. These data suggest that G-CSF following chemotherapy mobilizes both early and committed hemopoietic progenitors.
authors.affiliation: Department of Hematology, Sacro Cuore University, Roma, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Teofili
authors.forename: M S
authors.initials: MS
authors.lastname: Iovino
authors.forename: A
authors.initials: A
authors.lastname: Di Mario
authors.forename: E
authors.initials: E
authors.lastname: Ortu La Barbera
authors.forename: L
authors.initials: L
authors.lastname: Pierelli
authors.forename: S
authors.initials: S
authors.lastname: Bussa
authors.forename: C
authors.initials: C
authors.lastname: Rumi
authors.forename: G
authors.initials: G
authors.lastname: Menichella
authors.forename: G
authors.initials: G
authors.lastname: Leone
mesh_terms: D015703:Antigens, CD / Q000032:analysis*; D018952:Antigens, CD34; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D003114:Colony-Forming Units Assay; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology; D006410:Hematopoiesis; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D018189:Immunomagnetic Separation; D007378:Interleukins / Q000494:pharmacology; D008228:Lymphoma, Non-Hodgkin / Q000503:physiopathology / Q000628:therapy
chemical_list: D015703:Antigens, CD; D018952:Antigens, CD34; D007378:Interleukins; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor